Bristol Myers Squibb Forecasts 2024 Adjusted EPS Of $0.75-$0.95 Versus Prior Guidance Of $0.60-$0.90 And Consensus Of $0.71

Bristol-Myers Squibb Company -1.04%

Bristol-Myers Squibb Company

BMY

54.14

-1.04%

Financial Guidance 

Bristol Myers Squibb is raising its 2024 line-item guidance as noted below.

2024 Line-Item Guidance
  Non-GAAP2
  July 

(Prior)
October 

(Updated)
Total Revenues Upper end of low single- 

digit range
~5% increase
Total Revenues 

(excl. F/X)
Upper end of low single- 

digit range
~6% increase
Gross Margin % Between ~74% and ~75% Between ~74.5% and ~75%
Operating Expenses1 Low single-digit increase ~4% to ~5% increase
Other income/(expense) ~($50M) ~$125M
Effective tax rate ~66% ~60%
Diluted EPS $0.60 - $0.90 $0.75 - $0.95
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via